70. The Oncology Care Model and Medicare Payments, Utilization, and Quality.
作者: Gabriel A Brooks.;Matthew Trombley.;Sean McClellan.;Qing Zheng.;Mary Beth Landrum.;Van Doren Hsu.;Colleen M Kummet.;Pang-Hsiang Liu.;Derek Hoodin.;Colin Doyle.;Carol Simon.;Nancy L Keating.
来源: JAMA. 2026年
The Oncology Care Model (OCM) was the Centers for Medicare & Medicaid Services' first cancer-focused alternative payment model, running from 2016 to 2022. The OCM aimed to reduce Medicare spending and improve quality of care for patients receiving chemotherapy.
78. Diagnosis and Management of Resistant Hypertension: A Review.
作者: Michel Azizi.;Wanpen Vongpatanasin.;Naomi D L Fisher.;Felix Mahfoud.;Laurence Amar.;Ajay J Kirtane.
来源: JAMA. 2026年
Hypertension, defined as office systolic blood pressure (SBP) 130 mm Hg or greater and/or diastolic blood pressure 80 mm Hg or greater, affects 43.9% of women and 49.5% of men in the US. Approximately 19.7% of patients treated for hypertension have apparent resistant hypertension (blood pressure ≥130/80 mm Hg) despite using 3 or more antihypertensive medications, preferably a renin-angiotensin system blocker, a calcium channel blocker, and a thiazide-type diuretic, at maximally tolerated doses.
|